Cargando…

Omalizumab in the treatment of severe allergic (IgE-mediated) asthma: an update on recent developments

Detalles Bibliográficos
Autores principales:	Humbert, Marc, Canvin, Janice, Kiechle, Tamara, Lowe, Phil, Erpenbeck, Veit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3647304/ http://dx.doi.org/10.1186/2045-7022-3-S1-O12

Ejemplares similares

Omalizumab and IgE in the Control of Severe Allergic Asthma
por: Gon, Yasuhiro, et al.
Publicado: (2022)

Omalizumab in the management of patients with allergic (IgE-mediated) asthma
por: Sandström, Thomas
Publicado: (2009)

Specific IgE Response and Omalizumab Responsiveness in Severe Allergic Asthma
por: Tajiri, Tomoko, et al.
Publicado: (2023)

Inhibition of IgE and IgE/anti-IgE mediated responses in mast cells by Omalizumab
por: Kulka, M, et al.
Publicado: (2010)

A review of anti-IgE monoclonal antibody (omalizumab) as add on therapy for severe allergic (IgE-mediated) asthma
por: D’Amato, Gennaro, et al.
Publicado: (2007)

Reduction in oral corticosteroid use in patients with severe allergic (IgE-mediated) asthma receiving omalizumab in a real-world setting
por: Braunstahl, Gert-Jan, et al.
Publicado: (2013)

Treating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a review
por: D’Amato, Gennaro, et al.
Publicado: (2014)

Relevance of IgE to novel kiwi seed allergens evaluated in kiwi allergic children
por: Englund, Hillevi, et al.
Publicado: (2015)

Healthcare Resource Utilization in Patients Receiving Omalizumab for Allergic Asthma in a Real-World Setting
por: Braunstahl, Gert-Jan, et al.
Publicado: (2014)

Analysis of the IgE- and IgG-reactivity profiles of asthmatic and non-asthmatic HDM-allergic patients using the ISAC microarray system
por: Resch, Yvonne, et al.
Publicado: (2014)

The effect of omalizumab treatment on severe allergic asthma and allergic comorbidities: real-life experience from the Czech Anti-IgE Registry
por: Hutyrová, Beáta, et al.
Publicado: (2018)

Clinical Experience with Anti-IgE Monoclonal Antibody (Omalizumab) in Pediatric Severe Allergic Asthma—A Romanian Perspective
por: Berghea, Elena Camelia, et al.
Publicado: (2021)

Influence of the diagnosis chronic rhinosinusitis on asthma response to omalizumab in severe, uncontrolled asthmatics
por: Sintobin, Ina, et al.
Publicado: (2015)

Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange
por: Pennington, Luke F., et al.
Publicado: (2016)

Omalizumab for severe allergic asthma: a life changing drug?
por: Mesonjesi, Eris, et al.
Publicado: (2015)

Mutational analysis of immunodominant epitopes of caprine β-casein recognized by IgE antibodies from patients allergic to goat’s milk and tolerant to cow’s milk
por: Hazebrouck, S, et al.
Publicado: (2013)

Specific IgE responses in patients allergic to goat’s milk but tolerant to cow’s milk: involvement of minor differences in primary structure between caprine and bovine caseins
por: Ah-Leung, Sandrine, et al.
Publicado: (2011)

Positive food challenges despite negative specific IgE testing
por: Makatsori, Melina, et al.
Publicado: (2011)

Improvement in a human IgE-inducing system by in vitro immunization
por: Hashizume, Shuichi, et al.
Publicado: (2013)

Efficacy of Omalizumab Therapy in an Asthmatic with Low IgE
por: R, Divya, et al.
Publicado: (2020)

Chronic Rhinosinusitis with Nasal Polyps: Targeting IgE with Anti-IgE Omalizumab Therapy
por: Kariyawasam, Harsha H, et al.
Publicado: (2020)

A Phl p 7-specific IgG4 antibody inhibits allergic patients IgE cross-reactivity to allergens from the EF-hand family: importance of affinity and degree of cross-reactivity
por: Gadermaier, Elisabeth, et al.
Publicado: (2014)

A new humanized in vitro model of IgE-mediated rapid desensitization
por: Picard, Matthieu, et al.
Publicado: (2014)

Omalizumab for Severe Asthma: Beyond Allergic Asthma
por: Loureiro, C. C., et al.
Publicado: (2018)

IgG and IgE Autoantibodies to IgE Receptors in Chronic Spontaneous Urticaria and Their Role in the Response to Omalizumab
por: Maronese, Carlo Alberto, et al.
Publicado: (2023)

Omalizumab may decrease IgE synthesis by targeting membrane IgE+ human B cells
por: Chan, Marcia A, et al.
Publicado: (2013)

Effect of modification of peanut conglutin on IgE and T cell reactivity in adults with peanut allergy
por: van Hoffen, Els, et al.
Publicado: (2011)

In vitro digestions and IgE binding of proteins from white and whole hen’s egg
por: Martos, Gustavo, et al.
Publicado: (2011)

Increased allergen-specific IgG4 levels are linked to suppressed IgE titers when analysed by ISAC but not by immunocap
por: Hoffmann, Hans Jürgen, et al.
Publicado: (2014)

Current and future applications of the anti-IgE antibody omalizumab
por: Incorvaia, Cristoforo, et al.
Publicado: (2008)

Extracorporeal IgE Immunoadsorption in Allergic Asthma: Safety and Efficacy
por: Lupinek, Christian, et al.
Publicado: (2017)

Soybean allergy: IgE epitopes of glycinin (Gly m 6), an important soybean allergen
por: Schiller, Dirk, et al.
Publicado: (2014)

A study of the mechanisms of Anaphylaxis through passive transfer of IgE-mediated cutaneous reactivity
por: Pahlow Mose, Anja, et al.
Publicado: (2015)

Poster 1012: Safety and efficacy of omalizumab in 10 children with asthma and other allergic comorbidities
por: Aguiar, Rita, et al.
Publicado: (2014)

Is aboriginal food less allergenic? A study on the IgE-binding capacity of egg white and yolk from modern and ancient chicken breeds investigated in a cohort of hen’s egg allergic children
por: Gadermaier, Gabriele, et al.
Publicado: (2011)

Usefulness of the ratio total IgE / specific IgE (sIgE) to predict tolerance in children allergic to cow's milk proteins (CMP)
por: Machinena, A, et al.
Publicado: (2013)

Effect of individual allergen sensitization on omalizumab treatment outcomes in patients with severe allergic asthma determined using data from the Czech Anti-IgE Registry
por: Vaník, Petr, et al.
Publicado: (2020)

Healthcare utilization and indirect cost of treatment associated with severe allergic asthma in a real-world setting
por: Braunstahl, Gert-Jan, et al.
Publicado: (2013)

Pretreatment by omalizumab allows allergen-specific immunotherapy in children and young adult with severe allergic asthma
por: Lambert, Nathalie, et al.
Publicado: (2015)

Allosteric mechanism of action of the therapeutic anti-IgE antibody omalizumab
por: Davies, Anna M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6e4fp2cfv8mekmr3v8a5m8jfcm